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Scope: The effectiveness of maternal folate in reducing the risk of congenital
malformations during pregnancy is well established. However, the role of the
paternal folate status is scarcely investigated. The aim of this study is to
investigate the evidence of associations between the paternal folate status
and sperm quality, sperm epigenome, and pregnancy outcomes.
Methods and results: Databases are searched up to December 2017 resulting
in 3682 articles, of which 23 are retrieved for full-text assessment. Four out of
thirteen human and two out of four animal studies show positive associations
between folate concentrations and sperm parameters. An additional
meta-analysis of four randomized controlled trials in subfertile men shows
that the sperm concentration increases (3.54 95% confidence interval (CI)
[−1.40 to 8.48]) after 3–6 months of 5 mg folic acid use per day compared to
controls. Moreover, two out of two animal and one out of three human studies
show significant alterations in the overall methylation of the sperm
epigenome. One animal and one human study show associations between
low folate intake and an increased risk of congenital malformations.
Conclusions: This systematic review and meta-analysis shows evidence of
associations between paternal folate status and sperm quality, fertility,
congenital malformations, and placental weight.
Dr. J. Hoek, Prof. R. P. M. Steegers-Theunissen, Dr. S. P. Willemsen,
Dr. S. Schoenmakers
Department Obstetrics and Gynecology, Erasmus MC
University Medical Center
Rotterdam 3015GD, The Netherlands
E-mail: r.steegers@erasmusmc.nl
Dr. S. P. Willemsen
Department Biostatistics, Erasmus MC
University Medical Center
Rotterdam 3015GD, The Netherlands
The ORCID identification number(s) for the author(s) of this article
can be found under https://doi.org/10.1002/mnfr.201900696
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co.
KGaA, Weinheim. This is an open access article under the terms of the
Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly
cited.
DOI: 10.1002/mnfr.201900696
1. Introduction
The last three decades of research have
shown overwhelming evidence that the B
vitamin folate is essential for reproduc-
tion, pregnancy, health, and disease. In
preconception care, maternal folic acid
(FA) supplement use is well known for its
role in the prevention of congenital mal-
formations, in particular, neural tube de-
fects and congenital heart defects.[1] Due
to the proven protective role of FA in
human reproduction, the World Health
Organization advises all women to use
0.4 mg FA from the moment of contem-
plating pregnancy up to 12 weeks of ges-
tation. Van Uitert et al. showed in a sys-
tematic review that red blood cell (RBC)
folate concentrations and FA supplement
use is positively associated with an in-
creased birthweight and inversely associ-
ated with the risk of low birthweight and
small for gestation age infants.[2] These
effects can be explained by impaired
cell multiplication, DNA synthesis, and
programming due to (ir) reversible changes of the epigenome,
such as DNAmethylation, histone modifications, and chromatin
remodeling, induced during gametogenesis and the first weeks
after conception. The periconceptional epigenome of both men
and women, together with transcription factors, RNA and one-
carbon (1-C) moieties play key roles in molecular biological
processes, such as programming of gene expression, involved
in embryonic, fetal, and placental growth and development
(Figure 1a).[3]
Folate, but also methionine and choline, are important sub-
strates of the 1-C metabolism, which provides essential 1-C
moieties for processes such as lipid, nucleotide, protein, and
DNA synthesis, but also for methylation of DNA and histones.[4]
The main natural sources of folate are fruits, vegetables, and
nuts, which are absorbed from the jejunum as the biological
active form of tetrahydrofolate (THF). Another source is syn-
thetic FA derived from fortified foods and supplements, that
first need to be converted in the intestinal cells by dihydrofolate
reductase (enzyme commission number [ECN]: 1.5.1.3) to the
active form, THF. The next essential step is the conversion of
THF into 5-methyl-tetrahydrofolate (5-MTHF), by the enzyme
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methylenetetrahydrofolate reductase (MTHFR, ECN: 1.5.1.20). 5-
MTHF together with homocysteine is converted into methionine
by methionine synthase (MS) (ECN: 2.1.1.13) using vitamin B12
as cofactor. The folate-dependent 1-C metabolism is necessary
for the production of essential 1-C moieties (Figure 1b). Single
nucleotide polymorphisms (SNPs) in essential genes of the folate
dependent 1-C metabolism, such as MTHFR (ECN: 1.5.1.20),
can affect enzymatic activities and the availability of 1-Cmoieties.
Altogether, differences in the intake of folate, FA, and individual
SNPs, in tissues and target organs and the combination of all
these factors greatly influence the availability of 1-C moieties.
Since the embryo and fetus develop within the maternal envi-
ronment, it is not surprising that previous research has mainly
focused on the maternal folate status in relation to periconcep-
tional and pregnancy outcomes. Although the father-to-be also
contributes half of the genetic material to the offspring and the
placenta, the periconceptional paternal folate status has hardly
been investigated. This is surprising whereas it is known that pa-
ternal folate concentrations can affect sperm quality including
its DNA integrity and epigenome.[5–7] Therefore, we hypothesize
that the paternal folate status could not only affect DNA methy-
lation and sperm quality, but also fertility, and after successful
conception, miscarriage risk, embryonic growth, fetal and pla-
centation development, and pregnancy outcome.
Spermatogonial stem cells are present from birth but the
process of spermatogenesis only takes place in ≈2–3 months.
During spermatogenesis, millions of spermatozoa are produced
per day, indicating that the production of proteins and DNA are
needed on a large scale. In the human testes, the male germ
cells develop into spermatids and eventually into spermatozoa
(sperm), during spermiogenesis. The differentiation process of
spermiogenesis consists of major morphological and chemical
alterations and is necessary to ensure that the nuclear DNA will
be tightly compacted in the spermatozoal head. The histone
to protamine exchange, in which most histones are replaced
by protamines, allows a more condensed chromatin structure
allowing the tight formation of DNA (Figure 1a).[8] Interestingly,
retained histones with epigenetic information from the father
can be transferred to the conceptus. Since spermatogenesis
takes place in a relatively short time period, we hypothesize
that paternal nutrition and lifestyle can have a relatively direct
impact on reproductive success and pregnancy outcomes with
short and long-term health effects for the offspring. Herein, we
aim to give an overview of the evidence on associations between
the periconceptional paternal folate status and sperm quality,
pregnancy outcomes, and epigenetics (Figure 1a).
2. Experimental Section
2.1. Search Strategy
Searches were performed in the databases of Embase, Medline,
PubMed, Web of Science, the Cochrane databases, and Google
Scholar. The protocol for this systematic review was designed
and registered a priori at the PROSPERO registry (PROSPERO
2017: CRD42017080482). The search strategy terms used the
following MeSH terms including but not limited to FA, folate,
sperm, fertility, miscarriage, placenta, and pregnancy outcome
JeffreyHoek is aMDandPhD
candidate of thePericoncep-
tionEpidemiologyGroupas
part of the department ofOb-
stetrics andGynecology at
the ErasmusUniversityMed-
ical Center inRotterdam, the
Netherlands.He focuses
mainly on the role of thepa-
ternal influences onpericon-
ceptional outcomes.
(Table S2, Supporting Information). These were combined using
the Boolean operator “or”.
2.2. Inclusion and Exclusion Criteria
2.2.1. Systematic Review Eligibility Criteria
The paternal folate status was defined as folate concentrations
measured in blood or seminal plasma. Determinants of folate sta-
tus included in the search are intake of FA, folate intake, and 1-C
metabolism.
The main outcomes are divided in preconceptional and post-
conceptional outcomes. The preconceptional outcomes consisted
of sperm parameters (sperm concentration, sperm count), sperm
DNA damage, and sperm DNA-methylation. Fertility, time-to-
pregnancy, miscarriage, fetal growth (small for gestational age,
intra-uterine growth restriction, and birthweight), placentation,
and (preterm) birth were considered as postconceptional out-
comes. Databases were searched up and till December 2017. The
results of all the outcome searches were combined with “or”. The
results of the paternal folate status and outcome searches were
then combined with “and”.
Animal and human studies comprising experimental studies,
observational cohorts, case control studies, and randomized con-
trolled trials (RCTs) were eligible for inclusion in the review.
Letters, conference abstracts, editorials, and case reports were
excluded and the search was restricted to English language
papers.
Articles describing male participants with or without sperm
dysfunction were included, as were papers investigating admin-
istration of high or low doses of FA compared to a control dose.
Studies measuring folate concentrations in blood or seminal
plasma as exposure variable were also included. Maternal only as
well as combined paternal and maternal FA interventions were
excluded.
2.2.2. Study Selection, Full Text Review, and Data Extraction
J.H. and S.S. reviewed the titles and abstracts independently
from each other and selected papers for the full-text review. Next,
full text reviewing and data extraction were also independently
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Figure 1. Overview of a) the spermatogenesis, embryogenesis, the corresponding histone-protamine exchange, and the methylation level of non-
imprinted genes and b) folate related one-carbon metabolism. DHF, dihydrofolate; THF, tetrahydrofolate; 5,10-MTHF, 5,10-methylenetetrahydrofolate;
MTHFR,methylenetetrahydrofolate reductase; 5-MTHF, 5-methyltetrahydrofolate; MS,methionine synthase;SAM, S-adenosylmethionine. Dark blue box:
proteins; green box: enzymes; yellow box: vitamin/cofactor; light blue box: processes.
performed by J.H. and S.S. Data were put into a template, specif-
ically for this review. Differences were resolved by discussion be-
tween these authors. Any disagreements concerning the eligibil-
ity of particular studies were resolved through discussion with a
third reviewer (RST). Data extracted included the country of ori-
gin, year of publication, study design, study population (includ-
ing human or animal), sample size, exposures of interest, out-
come data, exclusion criteria, statistical analysis, potential con-
founders, results, and conclusion.
2.2.3. Quality of Study and Risk of Bias
To assess the quality of the human studies included in the review,
the ErasmusAGE quality score for systematic reviews was used:
a tool composed of five items based on previously published scor-
ing systems. Each of the five items can be allocated either zero,
one, or two points giving a total score between zero and ten, with
a score of ten representing a study of the highest quality. The five
items include study design (0 = cross-sectional study, 1 = longi-
tudinal study, 2 = intervention study), study size (0 = <50, 1 = 50
to 150, 2 = >150 participants), method of measuring exposure (0
= not reported, 1 =moderate quality exposure, 2 = good quality
exposure), method of measuring outcome (0 = no appropriate
outcome reported, 1 = moderate outcome quality, 2 = adequate
outcome quality), and analysis with adjustments (0 = no adjust-
ments, 1 = controlled for key confounders, 2 = additional adjust-
ments for confounders) (Table S1, Supporting Information).[9]
2.3. Meta-Analysis
An additional meta-analysis of only human data was conducted
to investigate the effects of 5 mg FA per day supplement use for
3–6 months in subfertile males on sperm concentration, sperm
motility, and normal spermmorphology. For the other outcomes
considered in this systematic review, unfortunately, not enough
information was available for meta-analysis.
The difference-in-difference of three outcomes is extracted and
pooled: sperm concentration, sperm motility, and normal sperm
morphology. The difference-in-difference is the difference be-
tween the effects of the treatment in the intervention and the
control group, where the effect of the treatment is measured as
the difference between the outcome after and before the inter-
vention. When no information was available of the effect on the
outcomes, it was computed based on the published baseline and
follow-up measurements. When standard deviations were not
given, they were calculated based on standard error and sam-
ple size or approximated using the interquartile range (using
the assumption of normality). None of the studies published
the standard error of the difference between the pre- and post-
intervention outcomes. To compute these, the estimates of the
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Figure 2. Flowchart of in- and excluded studies.
correlation were based between the two time points on the data
of Wong et al. The pooling of effects was done using a random-
effects model estimated by restricted maximum likelihood and
the heterogeneity was assessed using the I2-value. Pooled effects
with a p-value of 5%were considered significant. Anymultiplicity
adjustment was not applied.
3. Results and Discussion
3.1. Study Selection
The flowchart summarizes the process of literature search and
selection of studies (Figure 2). The initial search identified 3682
records of which 1216 were duplicates. Of the remaining 2466
records, a total of 2430 publications were excluded because they
did not fulfil the selection criteria. The full text of 36 papers were
read, 13 papers were excluded, resulting in 23 remaining articles
for analysis. The general characteristics of all included studies
and all specific concentrations of FA supplemented/deficient
animal diets are shown in Table 1. Of these 23 articles, 6 are an-
imal studies, 1 article combined a human and animal study, and
16 represent human studies, including 6 randomized controlled
trials (RCTs), 4 case-control studies, 3 cross-sectional studies,
2 intervention studies, 1 pre-post analysis, and 1 prospective
cohort study.
3.2. Preconceptional
A total of four studies investigated the associations between
folate status and sperm parameters in animals.[10–13] Further-
more, 13 articles reported on the association between folate
status and sperm parameters in human.[5–7,12,14–22] A total of five
studies investigated the association between folate status and
sperm epigenetics, of which two were animal studies[10,13] and
three were human studies.[5,12,23] Six studies investigated the
associations between folate status and sperm DNA damage and
apoptosis, including two animal studies[11,13] and four human
studies (Table 2).[7,19,21,24]
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Table 2. Description and summary of data from 19 studies that investigated associations between folate and sperm quality and sperm epigenetics.
Author Year Study type Synthetic/natural
folate
Sperm
parameters
Sperm
epigenetics
Sperm
DNA damage
Sperm
apoptosis
Lambrot et al. 2013 Animal study Synthetic = +/− − =
Swayne et al. 2012 Animal study Synthetic = −
Ly et al. 2017 Animal study Synthetic +/− +/−
Yuan et al. 2017 Animal study and case-control
study
Synthetic
Natural
+
+
=
Murphy et al. 2011 Case-control study Natural +
Wallock et al. 2001 Case-control study Natural +
Boxmeer et al. 2007 Cross-sectional study Natural =
Boxmeer et al. 2009 Cross-sectional study Natural − −
Crha et al. 2010 Cross-sectional study Natural =
Ebisch et al. 2006 Randomized controlled trial.
Data used is cross-sectional
Synthetic =
Ebisch et al. 2005 Randomized controlled trial Synthetic =
Boonyarangkul et al. 2015 Randomized controlled trial Synthetic + −
Da Silva et al. 2013 Randomized controlled trial Synthetic =
Raigani et al. 2014 Randomized controlled trial Synthetic = =
Wong et al. 2002 Randomized controlled trial Synthetic =
Chan et al. 2017 Retrospective intervention study Synthetic =
Landau et al. 1978 Prospective intervention study Synthetic =
Aarabi et al. 2015 Prospective intervention study Synthetic = +/− =
+, positive association; −, negative association; =, no association.
3.2.1. Sperm Parameters
Animal Studies: One study in mice comparing a 20-fold FA
fortified diet (40 mg kg−1) with a sevenfold FA deficient diet
(0.3 mg kg−1), starting during pregnancy through maternal ex-
posure and continued postnatally with a control diet (2 mg kg−1),
found that both diets resulted in decreased sperm counts.[10] One
study showed that a folate deficient diet (0.3 mg kg−1) resulted in
decreased sperm counts compared to a control (2 mg kg−1) diet
(9.3± 1.2× 106 vs 13.0± 1.1× 106).[12] Furthermore, Swayne et al.
found no significant differences regarding sperm count when
comparing a 6 mg kg−1 FA supplemented diet, starting during
early developmental in utero until just after weaning, compared
to a 2mg kg−1 control diet (14.0± 1.5× 106 vs 13.0± 1.1× 106).[11]
Another study showed no significant difference in sperm
count when mice received a folate deficient diet (0.3 mg kg−1
already started in utero through maternal exposure).[13]
In conclusion, animal studies show that both a FA supple-
mented and depleted diet can result in decreased sperm counts.
Human Studies: A total of five studies in human were de-
signed as randomized controlled trials investigating the effect of
FA supplement use on sperm parameters.[6,15,16,19,21] Of these five
RCTs, we could only use cross-sectional data from one study for
this systematic review.[16] Three RCTs reported no significant dif-
ferences regarding sperm volume, motility, and morphology in
the FA supplement user group (all 5 mg FA per day) as compared
to the control group.[6,15,19] On the other hand, one of the RCTs
showed a significant increase in sperm motility from 11.4% to
20.4% after 3 months of 5 mg per day FA supplement use.[21]
Only Raigani et al. showed that FA supplement use also caused
a significant increase in serum FA from 4 ng mL−1 at baseline
to 32.4 ng mL−1 after the intervention. Two non-randomized
intervention studies did not notice any effect on the same sperm
parameters after a 30-day trial of 10 mg FA supplementation and
after 6 months of 5 mg FA supplementation.[5,17]
The remaining seven human studies were either case-control
studies or cross-sectional study designs.[7,12,14,16,18,20,22] Four of
these studies showed significant associations between FA supple-
ment use and sperm parameters.[7,12,18,20] Wallock et al. showed
that in healthy males, folate concentrations measured in seminal
plasma (17.5 nmol L−1) correlated significantly with blood plasma
folate (10.3 nmol L−1; r= 0.76, p< 0.001) and that seminal plasma
folate significantly correlated with sperm density (r = 0.37, p <
0.05) and sperm total count (r = 0.31, p < 0.05).[20] In line with
this paper, Boxmeer et al. showed positive associations between
seminal plasma folate (25.3 nmol L−1) and blood plasma folate
(15.7 nmol L−1) in both fertile and subfertile men (r = 0.47, p <
0.001). Significant associations were found between blood folate
concentrations and sperm parameters, although seminal plasma
folate concentration was inversely correlated with ejaculate vol-
ume (r = −0.20,p < 0.01).[7] One case-control study showed that
serum and red blood cell (RBC) folate concentrations were sig-
nificantly lower in subfertile compared with fertile males (serum:
12.9 ± 5.9 and 14.7 ± 6.0 nmol L−1 (p = 0.006), respectively, and
RBC: serum: 649.1 ± 203.6 and 714.5 ± 223.4 nmol L−1 (p =
0.044), respectively.[18] In the logistic regression model, serum
folate was a significant predictor of subfertility, especially among
non-users of vitamins (odds ratio 0.36 [95% confidence interval
0.16–0.78]). In addition, men with azoospermia showed signif-
icantly lower seminal plasma folate concentrations than men
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with normozoospermia (respectively, 24.0 nmol L−1 (interquartile
range [IQR] 19.84–30.69) vs 26.2 nmol L−1 (IQR 21.7–34.8))[12]
and seminal plasma folate concentrations were significantly cor-
related with sperm density (r = 0.19,p < 0.01), but not with other
sperm parameters.
The other three out of these seven studies did not find
any associations between paternal folate status and sperm
parameters.[14,16,22] Chra et al. showed no significant differences
regarding both blood and seminal plasma folate on sperm
parameters, although in men with obstructive azoospermia,
higher seminal plasma folate concentrations were found com-
pared to non-obstructive azoospermia (31.5 vs 20.7 nmol L−1,
respectively).[22] When comparing blood and seminal plasma
folate concentrations between fertile and subfertile males,
two studies found no significant associations with sperm
parameters.[7,16]
The quality of abovementioned studies according to the Eras-
musAGE quality score ranged between 3 and 9, with the major-
ity (54%) having a score above 7. Although, the RCTs were ade-
quately designed according to the CONSORT statements,[25] the
number of included participants was low. Significantly positive
associations were reported in the large case-control studies of
Yuan et al. (n = 269) and Murphy et al. (n = 337), whereas the
smaller studies failed to show significance, which might be due
to underpowerment. The study of Aarabi et al. was initiated to in-
vestigate effects on methylation status of the sperm, but without
correcting for confounders. Of the remaining seven human stud-
ies, only two adjusted their statisticalmodel for confounders to al-
low adequate interpretation of the results; the studies of Boxmeer
et al. and Murphy et al. corrected for at least paternal age and
smoking. It is important to take confounders into consideration
since previous studies have shown that a diversity of conditions
and factors, such as smoking, alcohol use, age, and BMI also in-
fluence sperm parameters, which is in line with the induction
of excessive oxidative stress.[26–29] Although, less research is per-
formed on paternal influences on pregnancy outcomes, we as-
sume that the same confounding factors should be considered.
Only 7 out of 13 studies reported blood folate concentrations
in the study population, ranging from 9 to 73 nmol L−1, while
two reported concentrations before and after intervention.
Unfortunately, the effects of normal values of folate concentra-
tions regarding sperm quality are not mentioned. One might
hypothesize that only men with low folate concentrations benefit
from FA supplementation. This is supported by Murphy et al.,
who showed that an increase of folate from 13 to 25 nmol L−1
was associated with a significant increase in sperm parameters.
However, the study of Raigani et al. found an increase from 9 to
73 nmol L−1 without a significant effect on sperm parameters.
Meta-Analysis of Folic Acid Supplement Use and Sperm Param-
eters: Four studies were eligible for a meta-analysis to assess
the combined effect of FA supplement use on sperm parame-
ters in subfertile males.[6,15,19,21] Data of sperm concentration,
motility, and normal morphology were, respectively, analyzed
in a random-effects model to estimate the effect of daily 5 mg
FA treatment on each sperm parameter (Figure 3). The results
show that the sperm concentration was higher in patients after
FA supplement use compared to control (3.54 95%CI [−1.40
to 8.48]); however, these results were not significantly differ-
ent (p = 0.16). Sperm motility also did not significantly differ
after FA supplement use compared to controls (3.06 95%CI
[−1.36 to 7.48]) (p = 0.17). A non-significant decrease after FA
supplement use (−0.52 95%CI [−1.52 to 0.48]) was shown regard-
ing sperm normal morphology (p = 0.31). There was no evidence
of significant heterogeneity in the study populations regarding
concentration, motility, and normal morphology (I2 all 0%).
In conclusion, some human studies show associations be-
tween paternal folate status and sperm parameters. A meta-
analysis of four RCTs showed no significant differences regard-
ing sperm parameters after 5 mg per day FA supplementation.
Discussion: Decreased folate concentrations alter the 1-C
metabolism resulting in a reduced availability of 1-C groups and
building blocks for DNA synthesis and repair, which are essential
for successful spermatogenesis and genomic stability. Support-
ing this hypothesis, all non-randomized controlled trials stud-
ies showed significant associations between folate concentrations
and sperm parameters.[7,12,18,20] The suggestion that adequate fo-
late concentrations could serve as protection against DNA dam-
age is supported by an RCT showing a decrease in sperm DNA
damage after 3months of 5mg per day FA supplement use.[21] To
compensate for a possible folate deficiency, FA supplement use
will provide essential building blocks that could improve sperm
quality parameters. Although, three out of the four RCTs did not
find any significant improvements in sperm parameters after FA
supplement use,[6,15,19] Boonyarankul et al., showed a significant
increase in percentage of sperm motility (11.40–20.40%) after 3
months of 5 mg per day FA supplement use. Three out of the
four RCTs did not report whether folate concentrations in either
blood or RBCs increased after the FA intervention, while Raigani
et al. showed a significant increase in serum folate concentra-
tions. Taking measurement of folate concentrations along, ei-
ther in blood or RBCs, is especially interesting since there is het-
erogeneity in the data between before mentioned studies, which
might be explained by either subjects not daily taking FA, differ-
ences in folate absorption, or in the conversion of dihydrofolate
to tetrahydrofolate by intestinal dihydrofolate reductase.
In the additional meta-analysis, we did notice a trend indicat-
ing that 3–6 months of daily FA treatment of 5 mg per day im-
proves sperm volume and the percentage of sperm motility. The
non-significance of the meta-analysis can be explained by the rel-
atively small numbers of patients in each trial (N = 160 in total),
since in studies in women around 6500 participants were needed
to show significant effect on neural tube defects, for example.[1]
The relationship between low folate concentrations and
sperm quality seems explainable; however, the possible detri-
mental effect of too high folate concentrations is less clear.
It is hypothesized that excessive FA supplement use gives an
increase in dihydrofolate, with a negative feedback signal on
the MTHFR enzyme, thereby downregulating the biosynthesis
of 1-C groups. Without knowing the beneficial and detrimental
effects of exposure to different concentrations of FA, we should
be cautious with the global administration of high doses of FA
due to possible teratogenicity.[30]
3.2.2. Sperm DNA Damage and Methylation
Animal: Sperm DNA damage was investigated in two in-
dependent studies in mice, showing that a folate deficient diet
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Figure 3. Forest plot of the effect of 5 mg folic acid supplement use in subfertile men: a) sperm concentration, b) sperm motility, and c) sperm mor-
phology.
results in increased DNA damage.[11,13] Lambrot et al. showed an
increase in the expression of a histone variant (𝛾H2AX) involved
in repair of DNA double strand breaks, while the total number
of DNA double strand breaks in spermatocytes remained com-
parable between the groups indicating that DNA damage was
correctly repaired.[13]
Another way to measure DNA damage is via the DNA frag-
mentation index (DFI), where a higher DFI indicates more DNA
damage. Swayne et al. showed that mice weaned to a folate de-
ficient diet (see Table 1 for exact folic acid concentrations) had
an increased percentage DFI, compared to a control diet (5.0%
± 0.9 vs 2.6% ± 0.1, p = 0.04).[11] Furthermore, two other ani-
mal studies showed that a low intake of dietary folate resulted
in increased as well as decreased sperm DNA-methylation.[10,13]
Lambrot et al. showed that DNA methylation concentrations in
general were both increased and decreased for various genes in
the folate deficient group as compared to the control, while his-
tone methylation was primarily downregulated. No differences
regarding sperm apoptosis or methylation status of imprinted
genes were reported.[13] Ly et al. showed that both a high FA
supplemented and depleted diet resulted in increased variance
in methylation across imprinted genes, required for normal fetal
development.[10]
In conclusion, in animal models, an FA depleted diet results
in more sperm DNA damage and both increased and decreased
sperm DNA methylation.
Human: Sperm DNA damage was reported by four
studies.[5,7,19,21] Two RCTs reported a decrease in sperm DNA
damage after FA treatment.[19,21] Boonyarangkul et al. showed
a significant decrease in DNA tail length based on a Comet
assay, indicating less DNA damage, from 14.59 µm to 4.04 µm
(p <.05) after 3 months of 5 mg per day FA treatment.[21]
Raigani et al. showed a non-significant decrease in DFI after
a 16-week 5 mg per day FA intervention compared to placebo
(from 31.7 ± 14.8% to 24.3 ± 12% vs from 34.5 ± 19.7%
to 29.5 ± 10%, respectively).[19] Same results were shown
in the Aarabi study. One cross-sectional study showed that
only in the fertile male group, the seminal plasma folate
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Table 3. Description and summary of data from nine studies that investigated associations between folate and postconceptional outcomes.
Author Year Study type Synthetic/natural
folate
Fertility Miscarriage Birthweight Fetal
liver
Fetal
brain
Placenta Congenital
malformations
Kim et al. 2011 Animal study Synthetic = + +
Kim et al. 2013 Animal study Synthetic + + +
Lambrot et al. 2013 Animal study Synthetic + − = = −
Ly et al. 2017 Animal study Synthetic + = + = =
Mejos et al. 2013 Animal study Synthetic = +
Pauwels et al. 2017 Prospective cohort study Natural = =
Ratan et al. 2008 Case-control study Natural −
+, positive association; −, negative association; =, no association.
concentrations were negatively associated with DFI (r = −0.36,
p < 0.05).[7]
Annexin A5 (AnxA5) is commonly used to detect apoptotic
cells by its ability to bind to phosphatidylserine, amarker of apop-
tosis, which presents on the exterior part of the plasma mem-
brane. Hence, a high concentration of AnxA5 indicates high con-
centrations of apoptosis. Seminal AnxA5 was determined in one
RCT to assess the effect of FA supplement use on seminal apop-
tosis. After a 26week period of 5mg per day FA intervention there
was a slight decrease in AnxA5 in both fertile (from 5.6 to 5.4 µg
mL−1) and subfertile (from 5.4 to 5.2 µg mL−1) males; however, it
failed to reach significance.[24]
A total of three studies investigated the effect of folate status
on spermDNAmethylation.[5,12,23] The recent study of Chan et al.
showed that multiple years of FA food fortification in Canada had
no significant influence on sperm overall DNA methylation.[23]
However, 6 months of 5 mg per day FA supplement use caused
genome wide hypomethylation and hypermethylation covering
intergenic regions, introns, and exons of the sperm DNA.[5]
This effect is aggravated in individuals who are homozygous for
the MTHFR 677C>T polymorphism. Aarabi et al. found no ef-
fect of FA supplement use on the differentially methylated re-
gions of several imprinted genes.[5] A case-control study showed
no differences in methylation pattern of the promotor regions
of some spermatogenesis key-genes (Esr1, Cav1, and Elavl1) in
males with low versus high seminal plasma and blood folate
concentrations.[12]
The articles reporting on DNA damage were of good quality
(75% received a quality score of 8 or higher), whereas all stud-
ies investigating methylation of sperm were of low quality (66%
received a quality score of 4 or lower). Concerning potential con-
founders in these studies, two studies are designed as RCTs in
which correction for confounders is not needed. Boxmeer et al.
correctly adjusted for several confounding factors such as age,
BMI, smoking, and alcohol use, while the Aarabi et al. study did
not apply any correction for confounders.
In conclusion, in humans, multiple studies show that FA sup-
plementation results in a reduction in sperm DNA damage with
some studies showing that folate status is associated with the
sperm epigenome.
Discussion: Chronic exposure to high dose synthetic FA and
low folate concentrations seems to induce excessive oxidative
stress and as such cause increased cellular apoptosis and seminal
DNA damage. Techniques used to measure sperm DNA damage
included the sperm chromatin structure assay (SCSA; two stud-
ies), the comet assay (one study), and acridine orange staining
(AO-test; one study). While the SCSA and comet assay are both
sensitive and reliable, the AO-test appears to have a relative lack
of reproducibility.[31] A recent guideline regarding DNA damage
does not recommend using a specific technique, but mentions
that SCSA is one of the most used techniques. The low number
of studies (four in total) and the usage of different tests, do not
allow comparison between studies.
Folate is as substrate involved in the synthesis of lipids, pro-
teins, DNA, and RNA, the scavenging of reactive oxidative radi-
cals, DNA repair, and epigenetic. Thesemechanisms are involved
in cell multiplication and cell differentiation, apoptosis, signal-
ing, and programming and as such in spermatogenesis and em-
bryogenesis. Elevated levels of reactive oxygen species (ROS),
caused by various chronic diseases, obesity, genetic variations,
medication use, ageing, and an unhealthy diet and lifestyle, will
lead to oxidative stress, which is an important cause of DNA dam-
age. A crucial function of the 1-C cycle is scavenging of these reac-
tive oxygen species (ROS) by the anti-oxidant glutathione, which
is synthesized from folate together with homocysteine. Impor-
tantly, an unhealthy diet is associated with a decreased intake of
folate. Only when concentrations of methionine and especially
folate are sufficient, glutathione is formed. Low intake of FA and
folate are associated with an increase in oxidative stress thereby
altering DNA-integrity and subsequent molecular processes in-
volved in spermatogenesis and embryogenesis. The studies in
this review show that FA supplement use can result in decreased
sperm DNA damage.
3.3. Postconceptional
Seven articles reported on associations between paternal folate
status and the post-conceptional outcomes, such as fertility,
embryonic growth, miscarriage, fetal development, congenital
malformations, placentation, and pregnancy outcomes, of which
five were animal studies [10,13,32–34] and two were human studies
(Table 3).[35,36]
3.3.1. Fertility
Animal: Only one animal study showed that a folate deficient
diet in mice resulted in decreased pregnancy rates compared to
mice fed control diet (52.4% and 85.0%, respectively).[13]
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Human: There are no human studies reporting on fertility in
relation to paternal folate status.
Discussion: The overall results of the selected articles in this
review show that paternal folate status is often positively asso-
ciated with sperm parameters. The sperm parameters concen-
tration and percentage of mobile sperm are associated with fer-
tility and ongoing pregnancy rates.[37,38] Therefore, the reason-
ing is that in future, fathers’ optimization of folate status has
the potential to beneficially influence male fertility and preg-
nancy chances of a couple. Unfortunately, until now no human
studies have shown any effect of the paternal folate status on
pregnancy-chance. However, strong adherence of a couple to a
diet very rich in natural folate, like the Mediterranean diet, in-
creases the chance of an ongoing pregnancy after an IVF/ICSI
treatment.[39,40]
3.3.2. Embryonic Growth and Development
Animal: Two animal studies in mice investigated the asso-
ciation between the paternal FA supplement use and embryonic
growth and miscarriages.[10,13] Lambrot et al. showed that the
offspring of male mice, which had received a folate deficient
diet from early embryonic development onward (0.3 mg FA per
kg), did not differ regarding embryonic weight and crown rump
length (CRL) compared to male mice on a control diet (2 mg
kg−1). However, they found that a paternal folate deficient diet
resulted in a twofold increase of post-implantation embryonic
loss in mice.[13 ] Another animal study showed that male mice
fed a highly FA fortified diet (40 mg kg−1) have an increased risk
of post-implantation embryonic loss and their offspring show
growth restriction compared to control diet (2 mg kg−1).[10] In
conclusion, in animals, both very high and very low FA intake is
associated with an increased miscarriage rate.
Human: There are no human studies reporting on the asso-
ciation between paternal folate status and embryonic growth and
development or miscarriage.
Discussion: Shortly after conception, a global loss of methy-
lation at the level of DNA and histones takes place (Figure 1a).[41]
However both paternally and maternally imprinted genes, such
as insulin like growth factor (IGF-2), are unaffected by this
demethylation wave.[42] Since imprinting of these genes occurs
during the process of male and female gametogenesis, studying
the effects of periconceptional lifestyle factors on embryonic
health and health later in life, makes these genes of special inter-
est. Imprinted genes have a parent-of-origin effect by preferential
expression of either maternal or paternal inherited allele and em-
phasize the parental influence during the periconception period.
Altered sperm DNA methylation in genes for normal growth
and development of embryonic growth and development could
be affected by epigenetic imprinting.
3.3.3. Fetal Liver and Brain
Animal: The insulin-like-growth factor 2 (IGF-2) gene is pa-
ternally expressed and encodes for a protein that plays a major
role in regulating embryonic growth and development.[43] Three
animal studies investigated the effect of a paternal folate defi-
ciency on fetal liver outcomes.[32–34] All studies showed that the
fetal liver folate content was decreased after a paternal folate de-
ficient diet compared to control diet. Mejos et al. showed that a
folate deficient diet significantly decreased global hepatic DNA-
methylation concentrations with 37.9%, although no significant
differences in hepatic IGF-2 expression when compared to a fo-
late sufficient diet were detected.[34]
Two other animal studies investigated the association between
paternal folate status and brain development.[10,33] One study
showed that the total folate content of the fetal brain was com-
parable in rats on a folate deficient and control diet, whereas the
IGF-2 protein expression in the fetal whole brain was decreased
in former group.[33] Interestingly, they also found a significant
decrease in whole brain DNA-methylation, as measured by the
quantity of 5-methylcytosine (5-MC). The percentage of 5-MC de-
creases from 4.5% to 2.6% when comparing a folate sufficient
diet with a folate deficient diet. Another animal study that investi-
gated global brain methylation failed to see an effect of a paternal
high or low folate diet.[10] They did, however, find a significant
increase in variance of DNA methylation on a locus of the pater-
nally expressed gene 1 (PEG1) in the group supplemented with
high FA.
In conclusion, in animals all studies show an effect of paternal
folate diets on fetal liver contents while some indicate effects on
diverse fetal brain measurements.
Human: There are no human studies reporting on the fetal
development of brain and liver.
3.3.4. Congenital Anomalies
Animal: Two animal studies investigated the association be-
tween paternal folate status and congenital anomalies, of which
one found an association between a FA deficient diet compared to
control mice.[13] Lambrot et al. showed that in fathers on a folate
deficient diet, the percentage of litters with congenital malforma-
tions is significantly increased when compared to a control diet
(27% and 3%). The abnormalities consisted of craniofacial abnor-
malities, limb defects,muscle and skeletalmalformations.[13] An-
other study found no significant differences between male mice
on a control diet compared to those on high FA or low FA diet.[10]
In conclusion, in animals some studies show a negative asso-
ciation between FA intake and congenital malformations.
Human: One human study investigated the association be-
tween paternal folate status and congenital malformations.[36]
They found that the fathers of children born with neural tube de-
fects had significantly lower folate concentrations compared to
fathers of children born with other or without congenital malfor-
mations. Although, they reported an odds ratio for neural tube
defects of 5.2 (95%CI: 1.3–20.8) of offspring of fathers with low
folate concentrations, the effect diminished when adjusting for
potential confounders, which were unfortunately notmentioned.
In conclusion, in humans only one study showed a negative
association between folate intake and congenital malformations.
Discussion: Low intake of folate and low folate concentra-
tion are associated with increased sperm DNA damage and al-
terations in sperm epigenetics, which in case of successful fertil-
ization could interfere with embryonic development. The human
study underlines that paternal folate status can effect embryonic
growth, most likely by altering the sperm epigenome and thereby
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inducing adverse pregnancy outcomes.[36] However, results need
to be interpreted with caution since residual confounding can-
not be excluded due to the lack of mentioning of adjusted con-
founders (ErasmusAGE quality score of 3).
The number of women needed to use FA supplements peri-
conceptionally to prevent one child with a neural tube defect is
847 (NNT = 847).[44] For men, this number is most likely much
higher, since FA use by women directly affect the intrauterine en-
vironment and could potentially compensate for or correct pater-
nal effects of folate deficiencies. Males most likely pass on folate
effects via spermDNAmethylation changes and concentration in
seminal fluid.[45] More diverse and intensive human research is
necessary before we can translate the results of the mouse mod-
els to humans.
3.3.5. Placentation
Animal: Three animal studies describe the effect of paternal
folate on general aspects of placentation, such as weight, size,
and folate content.[10,13,32] Two studies did not find any significant
differences when comparing placenta weight and size between a
paternal FA deficient and control diet (see Table 1 for exact folic
acid concentrations).[10,13] Another study found a lower placen-
tal weight and a lower total placental folate content in the folate
deficient diet group compared to control.[32] Surprisingly, Lam-
brot et al. reported two fused placentas, which is considered to
be abnormal, out of the group of 35 pregnancies.
Regarding the methylation status of the placenta, one study
found no significant differences in global placental methylation
concentrations when comparing both low and high FA pater-
nal content diets compared to control.[10] However, in the group
with very high FA fortified diets (folate concentration 20 times
higher as compared to the control) compared to control diet,
inter-individual alterations in methylation across the paternally
expressed genes small nuclear ribonucleoprotein polypeptide N
and paternally expressed gene 3 were found.
Placental transporter proteins are necessary and essential for
the transport of micronutrients over the placental barrier. Of
these proteins, the placental folate receptor alpha enzyme is cru-
cial for the transport of folate over the placenta. Interestingly, Kim
et al. showed that a paternal folate deficient diet resulted in a
significant upregulation of this enzyme expression compared to
wildtype rats (2.3 times higher expression).
In conclusion, in animals some studies show a negative as-
sociation between paternal FA intake and placenta weight and
development and an association with alterations in placenta epi-
genetics.
Human: There are no human studies reporting on associa-
tions between paternal folate status and placental development.
Discussion: Paternally imprinted genes, which in general
are excluded from the postconceptional de- and remethylation
wave, are predominantly expressed in the placenta (Figure 1a).
External influences such as nutrition, lifestyle, and folate status
throughout the preconception stage can influence the definitive
epigenetic programming of (imprinted) genes, with potential
negative effects on embryonic but also placental development
postconceptionally. Micronutrients like iron, vitamin D, vitamin
A, folate, and vitamin B12 are necessary for normal placental
development. Deficiencies of these micronutrients in women
are associated with impaired placental development, which is
associated with negative pregnancy outcomes.[46] In women, FA
supplement use is also associated with placental development,
since placental weight at birth between women using FA sup-
plements versus women not using FA supplements is different
(643 grams vs 626 grams, respectively).[47] The causal effect of
these paternal factors remains to be elucidated, but epigenetic
programming of paternal origin is a plausible mechanism.
3.3.6. Pregnancy Outcome
Animal: Five animal studies investigated the association
between paternal folate status and birthweight.[10,13,32–34] Four
studies did not find an association between a folate deficient diet
and birthweight,[10,13,32,34] whereas a very high FA fortified diet
also did not alter birthweight compared to controls.[10] One ani-
mal study, however, showed that a folate deficient diet compared
to control diet resulted in lower birthweight (2.1–2.3 grams
[p < 0.001]) and smaller crown rump length (CRL) (3.3–3.4 cm
[p < 0.05]).[33] Interestingly, one study found an increase in
postnatal deaths when comparing both very high and low FA
fortified diets compared to control mice.[10]
In conclusion, in animals, a minority of studies showed an as-
sociation between paternal folate diet and pregnancy outcomes.
Human: There is one human study (ErasmusAGE quality
score of 8) reporting on birthweight, which found no significant
association between paternal folate intake, as measured by food
questionnaires, and birthweight of the offspring.[35]
4. Strengths and Limitations
The present work is the first to systematically review the currently
available evidence on the impact of the paternal folate status on
male fertility factors from sperm quality to pregnancy outcomes.
Due to the lack of human studies on paternal effects of FA supple-
ment use, we included animal studies to gain more insight into
the (patho)physiologic mechanisms and the (epi)genetic effects
of FA supplement use, resulting in a translational systematic re-
view. The review also includes an additionally performed meta-
analysis on the associations between paternal FA supplement use
ranging from 3 to 6 months and sperm parameters concentra-
tion, motility, and normal morphology. Despite our extensive lit-
erature search, the amount of evidence and quality of the studies
was relatively low. Regarding the included animal studies; in a
number of studies, the FA intervention already started in utero,
during the key time of parental erasure and reprogramming of
the germ cell epigenome and continuing postnatally for varying
amounts of time. The extended exposure might have lifelong ef-
fects on the male germ cell, perturbing prenatal and postnatal
germ cell development and epigenetics. Nevertheless, this review
provides some evidence that the periconceptional paternal folate
status or diet, can influence sperm parameters, fertility, embry-
onic growth, and pregnancy outcomes possibly explained via an
impaired embryonic and/or placental DNA synthesis and repair,
epigenetic programming, or cell multiplication.
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Unfortunately, optimal ranges of folate concentrations in
males are lacking in both human and animals, making compar-
isons between studies difficult. Several study results indicate that
either too low or too high concentrations are not beneficial. Be-
fore any general recommendations for paternal FA supplement
use can be issued, further investigation is necessary to better un-
derstand the contribution of the paternal folate status on fertility
and pregnancy outcomes, including placentation.
5. Conclusion
This translational systematic review shows that the paternal fo-
late status in humans and animals might be associated with
sperm quality and subsequent pregnancy outcomes, like fetal de-
velopment, placentation, and congenital malformations. As in
women, not only low but also high folate concentrations are as-
sociated with negative outcomes in men, such as poorer sperm
quality and an increased risk of congenital malformations. In
general, low paternal folate status is associated with poorer out-
comes, while deficiencies can easily be supplemented with FA
tablets and fortified diets. However, in recent years, the concerns
of high folate concentrations are increasing,[30] especially with
the worldwide increase of the use of multivitamin supplements
and FA fortified foods. Therefore, we have to be increasingly
aware of also the risk of harmful effects of too high (supplemen-
tary) folate concentrations in developed countries. Furthermore,
the results of this systematic reviewmake it clear that human data
on paternal folate status and fertility and pregnancy outcome is
very scarce. More research is necessary into the periconceptional
roles of paternal micronutrients. We need to understand the ef-
fects of paternal folate status on sperm epigenome and pericon-
ception outcomes, so we can optimally counsel future parents
during the periconception period.
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